Solesence Inc. (SLSN)
NASDAQ: SLSNConsumer DiscretionaryPackage Goods/CosmeticsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SLSN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $99.61M
- P/E (TTM)
- 47.00
- EPS (TTM)
- $0.03
- Dividend yield
- None
- 52-week range
- 0.61 – 2.30
- Day range
- 1.39 – 1.53
- Volume / Avg
- 146.03K / 392.50K
- Beta
- —
- Shares outstanding
- 70.65M
52-week range
SLSN stock today
On Nov 20, SLSN ended the session at $1.41, shedding $0.07 (4.73%), versus the S&P 500's 3.70% decline. Trading was light, with 146.03K shares changing hands, about 37% of the average daily volume. At this level, SLSN sits in the middle of its 52-week range of $0.61 to $2.30: 38.7% below the high, set on Nov 25, 2025 and 131.1% above the low.
SLSN is down 11.9% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 36.2%. At 47.0x trailing earnings, Solesence trades above the peer-group median of 10.8x.
Summary generated from market data by MetaCap's automated system. Methodology
About Solesence
Company profileSolesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products.
- Sector
- Consumer Discretionary
- Industry
- Package Goods/Cosmetics
- CEO
- Mr. Kevin Cureton
- Headquarters
- Romeoville, IL
- Employees
- 115
- Website
- solesence.com
Financial highlights
Full financialsIn fiscal 2025, Solesence generated $62.1 million in revenue, up 18.6% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $2.8 million (+155.6% year over year), for a net margin of 4.5% versus a median of 2.1% in the prior 5 years. Gross margin was 27.5% (up from 24.9%) and operating margin 4.2%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $62.06M | $52.35M | $37.30M | $37.32M | $29.48M |
| Growth | +18.56% | +40.35% | -0.05% | +26.61% | +72.14% |
| Net income | $2.81M | $1.10M | $-4.94M | $-2.62M | $2.32M |
| EPS (diluted) | $0.04 | $0.02 | $-0.10 | $-0.05 | $0.05 |
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 12, 2026
- EPS actual vs est.
- $-0.02 vs —
SLSN news
All SLSN newsSolesence peers
Consumer Discretionary sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| YSGYatsen Holding Limited ADR | 1.58 | -17.28% | $148.20M | vs SLSN |
| WNWMeiwu Technology Company Limited | 1.65 | -13.42% | $43.31M | vs SLSN |
| UGUnited-Guardian Inc. | 7.35 | +4.11% | $33.77M | vs SLSN |
| AXILAXIL Brands Inc. | 4.27 | -5.22% | $29.13M | vs SLSN |
| BYAHPark Ha Biological Technology Co. Ltd. Class A | 0.8501 | -18.26% | $16.59M | vs SLSN |
| CABRCaring Brands Inc. | 0.66 | 0.00% | $7.59M | vs SLSN |
| YCBDcbdMD Inc. | 0.36 | -5.11% | $4.84M | vs SLSN |
| BIOTInstinct Bio Technical Company Holdings Inc. | 0.1432 | -12.15% | $4.12M | vs SLSN |
Indexes, lists and sector
Largest Consumer Discretionary stocks
Solesence stock FAQ
What is Solesence's stock price today?
SLSN last traded at $1.41 as of Nov 20, 4:00 PM EST, down 4.73% on the day. Prices are delayed at least 15 minutes.
What is SLSN's P/E ratio?
SLSN trades at a trailing P/E ratio of 47.00, compared with a median of 10.8 for its closest peers.
Who is Solesence's CEO?
Mr. Kevin Cureton is the chief executive officer of Solesence Inc., which has about 115 employees.
What is the SLSN 52-week high?
The 52-week high for SLSN is $2.30 and the 52-week low is $0.61. The stock is currently 38.7% below its high.